Carrier cascade target delivery of 5-aminolevulinic acid nanoplatform to enhance antitumor efficiency of photodynamic therapy against lung cancer
Authors:
- 2 August 2024
- journal article
- research article
- Published by Elsevier in Journal of Photochemistry and Photobiology B: Biology
- Vol. 258, 112999
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- The tumor EPR effect for cancer drug delivery: Current status, limitations, and alternativesAdvanced Drug Delivery Reviews, 2022
- Recent advances in PLGA-based biomaterials for bone tissue regenerationActa Biomaterialia, 2021
- An Annexin V-FITC—Propidium Iodide-Based Method for Detecting Apoptosis in a Non-Small Cell Lung Cancer Cell Line2021
- Plasmonic Gold Nanoparticles (AuNPs): Properties, Synthesis and their Advanced Energy, Environmental and Biomedical ApplicationsChemistry – An Asian Journal, 2021
- Enhancement of tumor lethality of ROS in photodynamic therapyCancer Medicine, 2020
- Exploiting the dynamics of the EPR effect and strategies to improve the therapeutic effects of nanomedicines by using EPR effect enhancersAdvanced Drug Delivery Reviews, 2020
- Cell death in photodynamic therapy: From oxidative stress to anti-tumor immunityBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2019
- Fluorescent and mass spectrometric evaluation of the phagocytic internalization of a CD47-peptide modified drug-nanocarrierAnalytical and Bioanalytical Chemistry, 2019
- 5-aminolevulinic acid photodynamic therapy for the treatment of high-grade gliomasJournal of Neuro-Oncology, 2019
- Lung cancer specific and reduction-responsive chimaeric polymersomes for highly efficient loading of pemetrexed and targeted suppression of lung tumor in vivoActa Biomaterialia, 2018